{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T01:11:51Z","timestamp":1778461911009,"version":"3.51.4"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/cad.0b013e32835739fd","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T06:35:37Z","timestamp":1343111737000},"page":"43-51","source":"Crossref","is-referenced-by-count":24,"title":["An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect"],"prefix":"10.1097","volume":"24","author":[{"given":"Eric C.","family":"Bielefeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiemi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Coling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manna","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R.","family":"Fetoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"1-2","key":"R1-5-20210227","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention.","volume":"226","author":"Rybak","year":"2007","journal-title":"Hear Res"},{"key":"R2-5-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00464252","article-title":"Analysis of hearing loss due to cis-diamminedichloroplatinum-II.","volume":"239","author":"Van Zeijl","year":"1984","journal-title":"Arch Otorhinolaryngol"},{"key":"R3-5-20210227","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archotol.1997.01900090094014","article-title":"Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.","volume":"123","author":"Madasu","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R4-5-20210227","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J","article-title":"High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.","volume":"39","author":"Hayes","year":"1977","journal-title":"Cancer"},{"key":"R5-5-20210227","first-page":"19","article-title":"Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.","volume":"66","author":"Reddel","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"R6-5-20210227","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0378-5955(03)00142-4","article-title":"Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage.","volume":"182","author":"Sergi","year":"2003","journal-title":"Hear Res"},{"key":"R7-5-20210227","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/019459988108900226","article-title":"Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.","volume":"89","author":"Komune","year":"1981","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R8-5-20210227","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00454261","article-title":"Changes in the stria vascularis of the guinea pig due to cis-platinum.","volume":"239","author":"Tange","year":"1984","journal-title":"Arch Otorhinolaryngol"},{"key":"R9-5-20210227","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-5955(00)00059-9","article-title":"Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea.","volume":"144","author":"Cardinaal","year":"2000","journal-title":"Hear Res"},{"key":"R10-5-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00464398","article-title":"Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology.","volume":"242","author":"Boheim","year":"1985","journal-title":"Arch Otorhinolaryngol"},{"key":"R11-5-20210227","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0378-5955(96)00075-5","article-title":"Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants.","volume":"98","author":"Clerici","year":"1996","journal-title":"Hear Res"},{"key":"R12-5-20210227","first-page":"559","article-title":"Use of organotypic cultures of Cortis organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.","volume":"18","author":"Kopke","year":"1997","journal-title":"Am J Otol"},{"key":"R14-5-20210227","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.heares.2005.03.025","article-title":"Damage and threshold shift resulting from cochlear exposure to paraquat-generated superoxide.","volume":"207","author":"Bielefeld","year":"2005","journal-title":"Hear Res"},{"key":"R15-5-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5955(03)00344-7","article-title":"Noise induces A1 adenosine receptor expression in the chinchilla cochlea.","volume":"188","author":"Ramkumar","year":"2004","journal-title":"Hear Res"},{"key":"R16-5-20210227","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuroscience.2005.12.044","article-title":"Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin.","volume":"139","author":"Mukherjea","year":"2006","journal-title":"Neuroscience"},{"key":"R17-5-20210227","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/ars.2010.3110","article-title":"Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.","volume":"13","author":"Mukherjea","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"R18-5-20210227","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0773.1995.tb00167.x","article-title":"Mechanism of cisplatin ototoxicity: antioxidant system.","volume":"76","author":"Ravi","year":"1995","journal-title":"Pharmacol Toxicol"},{"key":"R19-5-20210227","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1097\/00001756-199808030-00034","article-title":"Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells.","volume":"9","author":"Liu","year":"1998","journal-title":"Neuroreport"},{"key":"R20-5-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5955(02)00634-2","article-title":"Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways.","volume":"174","author":"Devarajan","year":"2002","journal-title":"Hear Res"},{"key":"R21-5-20210227","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance.","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"R22-5-20210227","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0306-4522(03)00286-0","article-title":"Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis.","volume":"120","author":"Zhang","year":"2003","journal-title":"Neuroscience"},{"key":"R23-5-20210227","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1021\/pr8002479","article-title":"Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity.","volume":"7","author":"Jamesdaniel","year":"2008","journal-title":"J Proteome Res"},{"key":"R24-5-20210227","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/sj.bjp.0707405","article-title":"The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear.","volume":"152","author":"Garcia-Berrocal","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R25-5-20210227","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1620\/tjem.219.177","article-title":"Cisplatin ototoxicity and protection: clinical and experimental studies.","volume":"219","author":"Rybak","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"R26-5-20210227","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1254\/jjp.57.259","article-title":"The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices.","volume":"57","author":"Kameyama","year":"1991","journal-title":"Jpn J Pharmacol"},{"issue":"6B","key":"R27-5-20210227","first-page":"4547","article-title":"Effect of iron chelator, hydroxyl radical scavenger and cytochrome P450 inhibitors on the cytotoxicity of cisplatin to tumor cells.","volume":"20","author":"Liu","year":"2000","journal-title":"Anticancer Res"},{"key":"R28-5-20210227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/taap.2001.9171","article-title":"Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.","volume":"174","author":"Dehne","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"R29-5-20210227","doi-asserted-by":"crossref","first-page":"18674","DOI":"10.1074\/jbc.M111.297960","article-title":"Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.","volume":"287","author":"Jamesdaniel","year":"2012","journal-title":"J Biol Chem"},{"key":"R30-5-20210227","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0378-5955(96)00152-9","article-title":"D-Methionine provides excellent protection from cisplatin ototoxicity in the rat.","volume":"102","author":"Campbell","year":"1996","journal-title":"Hear Res"},{"key":"R31-5-20210227","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5955(99)00142-2","article-title":"D-Methionine protects against cisplatin damage to the stria vascularis.","volume":"138","author":"Campbell","year":"1999","journal-title":"Hear Res"},{"key":"R32-5-20210227","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00005537-200107000-00005","article-title":"L-N-Acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity.","volume":"111","author":"Feghali","year":"2001","journal-title":"Laryngoscope"},{"key":"R33-5-20210227","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00016480410016559","article-title":"Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity.","volume":"124","author":"Fetoni","year":"2004","journal-title":"Acta Otolaryngol"},{"key":"R34-5-20210227","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00001813-200506000-00013","article-title":"Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity.","volume":"16","author":"Lynch","year":"2005","journal-title":"Anticancer Drugs"},{"key":"R35-5-20210227","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.heares.2006.11.012","article-title":"Prevention of noise- and drug-induced hearing loss with D-methionine.","volume":"226","author":"Campbell","year":"2007","journal-title":"Hear Res"},{"key":"R36-5-20210227","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/269346a0","article-title":"Identification of a transformation-specific antigen induced by an avian sarcoma virus.","volume":"269","author":"Brugge","year":"1977","journal-title":"Nature"},{"key":"R37-5-20210227","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","article-title":"Cellular functions regulated by Src family kinases.","volume":"13","author":"Thomas","year":"1997","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R38-5-20210227","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","article-title":"Role of Src expression and activation in human cancer.","volume":"19","author":"Irby","year":"2000","journal-title":"Oncogene"},{"key":"R39-5-20210227","first-page":"109","article-title":"The role of E-cadherin and scatter factor in tumor invasion and cell motility.","volume":"59","author":"Behrens","year":"1991","journal-title":"EXS"},{"key":"R40-5-20210227","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1038\/sj.onc.1208080","article-title":"The interplay between Src and integrins in normal and tumor biology.","volume":"23","author":"Playford","year":"2004","journal-title":"Oncogene"},{"key":"R41-5-20210227","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.heares.2005.04.009","article-title":"Prevention of noise-induced hearing loss with Src-PTK inhibitors.","volume":"208","author":"Harris","year":"2005","journal-title":"Hear Res"},{"key":"R42-5-20210227","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/1463-1741.31875","article-title":"A comparison of the protective effects of systemic administration of a pro-glutathione drug and a Src-PTK inhibitor against noise-induced hearing loss.","volume":"7","author":"Bielefeld","year":"2005","journal-title":"Noise Health"},{"key":"R43-5-20210227","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/1463-1741.82962","article-title":"Postexposure treatment with a Src-PTK inhibitor in combination with N-l-acetyl cysteine to reduce noise-induced hearing loss.","volume":"13","author":"Bielefeld","year":"2011","journal-title":"Noise Health"},{"key":"R44-5-20210227","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neures.2011.07.1836","article-title":"Protection from impulse noise-induced hearing loss with novel Src-protein tyrosine kinase inhibitors.","volume":"71","author":"Bielefeld","year":"2011","journal-title":"Neurosci Res"},{"key":"R45-5-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jnci\/55.3.555","article-title":"Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor.","volume":"55","author":"Von Kleist","year":"1975","journal-title":"J Natl Cancer Inst"},{"key":"R46-5-20210227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1139\/o99-068","article-title":"Superoxide generation and tyrosine kinase.","volume":"78","author":"Yang","year":"2000","journal-title":"Biochem Cell Biol"},{"key":"R47-5-20210227","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10623320390272280","article-title":"Endothelial NADPH oxidase: mechanism of activation by low-density lipoprotein.","volume":"10","author":"ODonnell","year":"2003","journal-title":"Endothelium"},{"key":"R48-5-20210227","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1016\/j.ejmech.2011.07.050","article-title":"Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities.","volume":"46","author":"Fallah-Tafti","year":"2011","journal-title":"Eur J Med Chem"},{"key":"R49-5-20210227","first-page":"1717","article-title":"A study of chromosome 6 allele loss in human colorectal carcinomas.","volume":"12","author":"Wildrick","year":"1992","journal-title":"Anticancer Res"},{"key":"R50-5-20210227","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/MCB.15.5.2374","article-title":"Src activity increases and yes activity decreases during mitosis of human colon carcinoma cells.","volume":"15","author":"Park","year":"1995","journal-title":"Mol Cell Biol"},{"key":"R51-5-20210227","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1349-7006.1998.tb00512.x","article-title":"A novel mutant from apoptosis-resistant colon cancer HT-29 cells showing hyper-apoptotic response to hypoxia, low glucose and cisplatin.","volume":"89","author":"Suzuki","year":"1998","journal-title":"Jpn J Cancer Res"},{"key":"R52-5-20210227","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/cbdv.200890152","article-title":"Terpene conjugates of diaminedichloridoplatinum(II) complexes: antiproliferative effects in HL-60 leukemia, 518A2 melanoma, and HT-29 colon cancer cells.","volume":"5","author":"Bernhardt","year":"2008","journal-title":"Chem Biodivers"},{"key":"R53-5-20210227","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s002800100363","article-title":"In vitro studies on the mechanisms of oxaliplatin resistance.","volume":"48","author":"Hector","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"R54-5-20210227","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910500502","article-title":"Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells.","volume":"50","author":"Dimanche-Boitrel","year":"1992","journal-title":"Int J Cancer"},{"key":"R55-5-20210227","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1203668","article-title":"Spontaneous development of tumor resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells.","volume":"19","author":"Branch","year":"2000","journal-title":"Oncogene"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e32835739fd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:17:37Z","timestamp":1620947857000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201301000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32835739fd","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}